Acquisition - September 5, 2023
Dynamic Code acquires FindOut Diagnostic
Dynamic Code has acquired the bankrupt FindOut Diagnostic, a medical technology company that develops and manufactures self-tests. The company launched self-tests for CRP (rapid lowering) and HbA1c (long-term blood sugar) at the beginning of the year. The company’s products are well in line with Dynamic Code’s strategy to expand the product portfolio, the company states. […]
MedTech Business - August 23, 2023
Episurf’s first commercial case in the US scheduled
Episurf Medical has announced that the company’s first commercial case in the US has been scheduled for surgery. This is also the first case ever with the newly introduced product Episealer Patellofemoral System, states the company. The product is a fully individualized implant system for patients with isolated osteoarthritis of the patellofemoral joint in the […]
MedTech Business - August 22, 2023
Bico announces goodwill impairment and its CEO steps down
The Group has resolved on non-cash flow affecting one-off items predominantly related to goodwill impairment due to increased WACC for group companies, write-down of assets and revised earn-out estimates. This results in an effect on EBITDA of 94 million SEK and -830 million SEK on EBIT in Q2 2023. Erik Gatenholm steps down The Group […]
Acquisition - August 8, 2023
ADDvise acquires Diabetic Supplies
ADDvise Group has entered into a share purchase agreement with the owners of Diabetic Supplies Inc regarding the acquisition of all shares of Diabetic Supplies. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue for the last twelve months per June 30, 2023, amounted to USD […]
Acquisition - August 7, 2023
Elos Medtech acquires Klingel Medical
Elos Medtech has entered into an agreement to acquire Klingel Holding from IK Partners and management. Klingel, a leading contract development and manufacturing organization (CDMO) headquartered in Germany, will strengthen Elos Medtech’s position with extraordinary R&D capabilities and new technology expertise, the company states. Further, the acquisition will broaden the product offering and add new […]
MedTech Business - July 5, 2023
Devyser has inaugurated its CLIA-certified laboratory
The new laboratory in Atlanta, Georgia, will offer clinical test services for hereditary diseases, oncology, and post-transplant monitoring. The laboratory has already processed its first commercial test, examining a patient sample for fetal Rhesus D blood group status, states the company in a press release. “The opening of our new CLIA-certified laboratory in Atlanta is […]
